Intelligent Bio Solutions Expands Global Reach with SmarTest Patch Agreement.

Intelligent Bio Solutions has partnered with SMARTOX to distribute its SmarTest Patch drug detection product globally, excluding the US and Canada. This agreement reinforces the company's expansion plans and prioritizes FDA approval. The partnership builds on the existing relationship between INBS and SMARTOX, which has been distributing INBS' Intelligent Fingerprinting Drug Testing Solution in the forensic market in the US.

Intelligent Bio Solutions Inc. (INBS) has announced a significant milestone in its global expansion strategy by partnering with SMARTOX to distribute its SmarTest Patch drug detection product internationally, excluding the United States and Canada [1]. This agreement further strengthens INBS's position as a leading provider of non-invasive drug testing solutions.

The SmarTest Patch, a discreet and tamper-evident device worn on the skin for 7 to 10 days, continuously collects sweat to detect various substances, including cocaine, opiates, methamphetamines, marijuana, and fentanyl [2]. The addition of this product to INBS's portfolio enhances its ability to address both short-term and continuous detection needs through sweat-based, non-invasive methods.

The partnership with SMARTOX, a U.S.-based provider of drug and alcohol testing products and services, builds on the existing relationship between INBS and SMARTOX, which has been distributing INBS's Intelligent Fingerprinting Drug Testing Solution in the forensic market in the US. This collaboration opens new opportunities for INBS, particularly in the justice and rehabilitation sectors, where the global drug testing market is projected to grow significantly, reaching approximately $18.6 billion by 2030 [1].

As part of its U.S. expansion strategy, INBS continues to prioritize securing FDA clearance for its fingerprint sweat-based drug testing technology for use beyond Forensic Use Only settings. The company remains actively engaged with regulatory consultants and stakeholders to bring its innovative solution to market in the US for organizations seeking reliable, dignified, and non-invasive drug screening alternatives [1].

INBS currently delivers non-invasive drug testing solutions to over 450 active accounts in 24 countries, supporting clients across health, justice, and workplace sectors. This new distribution agreement with SMARTOX further positions INBS to expand its global presence and introduce an additional revenue stream aligned with its broader expansion goals.

References:
[1] https://www.marketscreener.com/quote/stock/INTELLIGENT-BIO-SOLUTIONS-124598166/news/Intelligent-Bio-Solutions-Inc-Announces-New-Global-Distribution-Agreement-with-SMARTOX-50526698/
[2] https://finance.yahoo.com/news/exclusive-intelligent-bio-targets-global-120302704.html